Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Plebanski

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Frontiers in Immunology|August 21, 2023
Editorial: The role of TNF-TNFR2 signal in immunosuppressive cells and its therapeutic implications, volume IIXin Chen, Magdalena Plebanski
Frontiers in Immunology|September 27, 2019
Editorial: The Role of TNF-TNFR2 Signal in Immunosuppressive Cells and Its Therapeutic ImplicationsXin Chen, Magdalena Plebanski
Expert Review of Vaccines|July 1, 2016
Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploitedKatie L Flanagan, Magdalena Plebanski
Trends in Parasitology|February 8, 2017
The Economics of Malaria Vaccine DevelopmentMagdalena Plebanski, Katie L Flanagan
European Journal of Immunology|April 7, 2011
CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigmsKaren Scalzo-Inguanti, Magdalena Plebanski
Molecular Immunology|January 13, 2018
The emerging role of nanomaterials in immunological sensing - a brief reviewSimon R Corrie, Magdalena Plebanski
Methods (San Diego, Calif.)|June 15, 2013
Nanotechnology and vaccine development: methods to study and manipulate the interaction of nanoparticles with the immune systemMagdalena Plebanski, Sue D Xiang
Nature Communications|April 15, 2025
Recent perspectives in clinical development of malaria vaccinesJack Feehan, Magdalena Plebanski, Vasso Apostolopoulos
Current Topics in Medicinal Chemistry|October 5, 2006
Regulatory T-cells: immunomodulators in health and diseaseKaren Scalzo, Magdalena Plebanski, Vasso Apostolopoulos
RSC Advances|May 25, 2026
Advancements in the manufacturing routes for the synthesis of marketed PARP inhibitorsDhurgam Rani, Magdalena Plebanski, Tanmay Chatterjee
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|August 21, 2023
Editorial: The role of TNF-TNFR2 signal in immunosuppressive cells and its therapeutic implications, volume IIXin Chen, Magdalena Plebanski
Frontiers in Immunology|September 27, 2019
Editorial: The Role of TNF-TNFR2 Signal in Immunosuppressive Cells and Its Therapeutic ImplicationsXin Chen, Magdalena Plebanski
Expert Review of Vaccines|July 1, 2016
Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploitedKatie L Flanagan, Magdalena Plebanski
Trends in Parasitology|February 8, 2017
The Economics of Malaria Vaccine DevelopmentMagdalena Plebanski, Katie L Flanagan
European Journal of Immunology|April 7, 2011
CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigmsKaren Scalzo-Inguanti, Magdalena Plebanski
Molecular Immunology|January 13, 2018
The emerging role of nanomaterials in immunological sensing - a brief reviewSimon R Corrie, Magdalena Plebanski
Methods (San Diego, Calif.)|June 15, 2013
Nanotechnology and vaccine development: methods to study and manipulate the interaction of nanoparticles with the immune systemMagdalena Plebanski, Sue D Xiang
Nature Communications|April 15, 2025
Recent perspectives in clinical development of malaria vaccinesJack Feehan, Magdalena Plebanski, Vasso Apostolopoulos
Current Topics in Medicinal Chemistry|October 5, 2006
Regulatory T-cells: immunomodulators in health and diseaseKaren Scalzo, Magdalena Plebanski, Vasso Apostolopoulos
RSC Advances|May 25, 2026
Advancements in the manufacturing routes for the synthesis of marketed PARP inhibitorsDhurgam Rani, Magdalena Plebanski, Tanmay Chatterjee
Pageof 22